SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Schedule of impact of new accounting guidance

The impact of adopting the accounting guidance on the Company's consolidated statement of operations for the year ended June 30, 2019 was as follows (in thousands):

	Year Ended June 30, 2019
	As Reported		Adjustments		Balance Without Adoption
Revenues	$	44,312	$	267	$	44,579
Cost of revenues	31,042		162		31,204
Gross profits	13,270		105		13,375
Selling, general and administrative	12,003		49		12,052
Operating income	447		56		503
Net income	$	214	$	56	$	270

Summary of revenue by solution

The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (dollar amounts in thousands):

	Year Ended June 30,
	2020		% Total		2019		% Total		2018		% Total
REVENUES BY SOLUTION:
Mailbacks	$	26,578	52.0	%	$	24,501	55.2	%	$	22,272	55.5	%
Route-based pickup services	10,390		20.3	%	9,029		20.4	%	7,492		18.7	%
Unused medications	9,163		17.9	%	6,936		15.7	%	5,907		14.7	%
Third party treatment services	247		0.5	%	290		0.7	%	891		2.2	%
Other (1)	4,768		9.3	%	3,556		8.0	%	3,579		8.9	%
Total revenues	$	51,146	100.0	%	$	44,312	100.0	%	$	40,141	100.0	%

(1)The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations.

Schedule of allowance for doubtful accounts

See rollforward of allowance activity below:

Allowance for Doubtful Accounts	Balance Beginning of Year		Charges to Expense		Write-offs /Recoveries		Balance End of Year
2020	$	132	$	111	$	(81)	$	162
2019	$	102	$	81	$	(51)	$	132
2018	$	78	$	62	$	(38)	$	102

Schedule of stock-based compensation expense

Total stock-based compensation expense for the fiscal years ended June 30, 2020, 2019 and 2018 are as follows:

	Year Ended June 30,
	2020		2019		2018
Stock-based compensation expense included in:
Cost of revenue	$	4	$	9	$	43
Selling, general and administrative	514		391		433
Total	$	518	$	400	$	476

Schedule of stock option valuation assumptions

The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

	Year Ended June 30,
	2020		2019		2018
Weighted average risk-free interest rate	0.3	%	2.6	%	1.2	%
Weighted average expected volatility	49	%	44	%	48	%
Weighted average expected life (in years)	3.13		3.08		3.03
Dividend yield	—		—		—

Schedule of inventory

The components of inventory are as follows (in thousands):

	As of June 30,
	2020		2019
Raw materials	$	1,402	$	1,273
Finished goods	5,300		3,543
Total inventory	6,702		4,816
Less: current portion	5,638		3,770
Inventory, net of current portion	$	1,064	$	1,046

Schedule of accrued liabilities

The components of Accrued Liabilities on the balance sheet as of June 30, 2020 and 2019 are as follows:

	As of June 30,
	2020		2019 (1)
Accrued payroll	$	509	$	376
Customer-related payables	1,108		834
Other	1,216		1,003
Total	$	2,833	$	2,213

(1) Certain prior year amounts have been reclassified to conform to current year presentation.